Securities code: 000504 securities abbreviation: Nanhua Bio-Medicineco.Ltd(000504) Announcement No.: 2022-016
Nanhua Bio-Medicineco.Ltd(000504)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. The shareholders’ meeting did not veto the proposal;
2. This general meeting of shareholders does not involve changing the resolutions adopted by previous general meetings of shareholders.
1、 Convening and attendance of the meeting
(I) convening of the meeting
1. Meeting time:
(1) On site meeting time: 15:00 PM, February 17, 2022
(2) Online voting time: Thursday, February 17, 2022. Among them: the specific time of online voting through the trading system of Shenzhen stock exchange is 9:15-9:25, 9:30-11:30 and 13:00-15:00 on February 17, 2022; The time for online voting through the Internet voting system is 9:15-15:00 on February 17, 2022.
2. Venue of the meeting: conference room on the third floor, building B1, Lugu science and technology innovation and entrepreneurship Park, No. 1698, Yuelu West Avenue, Changsha high tech Development Zone
3. The way of holding the meeting: the combination of on-site voting and online voting
4. Convener: the 11th board of directors of the company
5. Moderator: Mr. Yang Yun, chairman
6. Legality and compliance of the meeting: the convening of the general meeting of shareholders complies with the provisions of the company law, the securities law, the rules for the general meeting of shareholders of listed companies and other laws, regulations and the articles of association.
(II) overall situation of shareholders attending the meeting:
1. Overall attendance:
There are 4 shareholders voting on site and online, representing 115325355 shares, accounting for 37.0138% of the total shares of the listed company. Among them, there are 3 shareholders voting on site, representing 115301755 shares, accounting for 37.0062% of the total shares of the listed company. One shareholder voted online, representing 23600 shares, accounting for 0.0076% of the total shares of the listed company.
2. Overall attendance of minority shareholders: there are 2 minority shareholders voting on site and online, representing 23700 shares, accounting for 0.0076% of the total shares of the listed company. Among them, there is one minority shareholder voting on site, representing 100 shares, accounting for 0.0000% of the total shares of the listed company. One minority shareholder voted online, representing 23600 shares, accounting for 0.0076% of the total shares of the listed company.
3. Some directors, supervisors, senior managers and lawyers of the company attended or attended the meeting as nonvoting delegates.
2、 Deliberation and voting of proposals
The shareholders’ meeting voted on the proposal by combining on-site voting and online voting. The specific voting results are as follows:
1. The proposal on the remuneration scheme of the company’s directors and supervisors was reviewed and approved
The total number of effective voting shares of the proposal is 115325355. After voting, 115301755 shares were approved, accounting for 99.9795% of the shares held by all shareholders attending the meeting; Against 23600 shares, accounting for 0.0205% of the shares held by all shareholders attending the meeting; Abstain from 0 shares, accounting for 0.0000% of the shares held by all shareholders attending the meeting.
Voting of minority shareholders: 100 shares agreed, accounting for 0.4219% of the shares held by minority shareholders attending the meeting; Against 23600 shares, accounting for 99.5781% of the shares held by minority shareholders attending the meeting; Abstained 0 shares, accounting for 0.0000% of the shares held by minority shareholders attending the meeting.
2. The proposal on using temporarily idle funds to invest in short-term financial products of low-risk banks was considered and adopted
The total number of effective voting shares of the proposal is 115325355. After voting, 115301755 shares were approved, accounting for 99.9795% of the shares held by all shareholders attending the meeting; 0 dissenting shares, accounting for 0.0000% of the shares held by all shareholders attending the meeting; 23600 shares were abstained, accounting for 0.0205% of the shares held by all shareholders attending the meeting.
Voting of minority shareholders: 100 shares agreed, accounting for 0.4219% of the shares held by minority shareholders attending the meeting; 0 opposition shares, accounting for 0.0000% of the shares held by minority shareholders attending the meeting; 23600 shares were abstained, accounting for 99.5781% of the shares held by minority shareholders attending the meeting.
3. The proposal on purchasing directors, supervisors and senior managers’ liability insurance was deliberated and adopted
The total number of effective voting shares of the proposal is 115325355. After voting, 115301755 shares were approved, accounting for 99.9795% of the shares held by all shareholders attending the meeting; 0 dissenting shares, accounting for 0.0000% of the shares held by all shareholders attending the meeting; 23600 shares were abstained, accounting for 0.0205% of the shares held by all shareholders attending the meeting.
Voting of minority shareholders: 100 shares agreed, accounting for 0.4219% of the shares held by minority shareholders attending the meeting; 0 opposition shares, accounting for 0.0000% of the shares held by minority shareholders attending the meeting; 23600 shares were abstained, accounting for 99.5781% of the shares held by minority shareholders attending the meeting.
3、 Legal opinions issued by lawyers
1. Name of law firm: Hunan Qiyuan law firm
2. Name of Lawyer: Liang Shuang, Zhang Yingqi
3. Concluding observations:
The lawyers of the firm believe that the convening and convening procedures of the general meeting of shareholders comply with the provisions of the company law, the rules of the general meeting of shareholders and other laws, regulations, normative documents and the articles of Association; The qualifications of the attendees and conveners of the shareholders’ meeting are legal and valid; The voting procedures and results of this general meeting of shareholders are legal and valid.
4、 Documents for future reference
1. Resolutions of the general meeting of shareholders signed and sealed by the directors attending the meeting;
2. Legal opinion on the first extraordinary general meeting of shareholders in Nanhua Bio-Medicineco.Ltd(000504) 2022 issued by Hunan Qiyuan law firm.
It is hereby announced.
Nanhua Bio-Medicineco.Ltd(000504) board of directors February 18, 2022
